[1] T. Ozawa, D. Paviour, N.P. Quinn, K.A. Josephs, H. Sangha, L. Kilford, D.G. Healy, N.W. Wood, A.J. Lees, J.L. Holton, T. Revesz, The spectrum of pathological involvement of the striatonigral and olivopontocerebellar systems in multiple system atrophy: Clinicopathological correlations, Brain 127 (12) (2004) 2657–2671, https://doi.org/10.1093/brain/awh303. Pubmed:15509623.
[2] D.W. Dickson, W.L. Lin, W.K. Liu, S.H. Yen, Multiple system atrophy: A sporadic synucleinopathy, Brain Pathol. 9 (4) (1999) 721–732, https://doi.org/10.1111/ j.1750-3639.1999.tb00553.x. Pubmed:10517510.
[3] G.K. Wenning, Y. Ben-Shlomo, M. Magalh˜ aes, S.E. Daniel, N.P. Quinn, Clinicopathological study of 35 cases of multiple system atrophy, J. Neurol. Neurosurg. Psychiatry 58 (2) (1995) 160–166, https://doi.org/10.1136/ jnnp.58.2.160. Pubmed:7876845.
[4] R. Radford, A. Rcom-H’cheo-Gauthier, M.B. Wong, E.D.M. Quilty, Eaton, C. Blizzard, A. Norazit, A. Meedeniya, J.C. Vickers, W.P. Gai, G.J. Guillemin, A. K. West, T.C. Dickson, R. Chung, D.L. Pountney, The degree of astrocyte activation in multiple system atrophy is inversely proportional to the distance to α-synuclein inclusions, Mol. Cell. Neurosci. (2015), https://doi.org/10.1016/j. mcn.2015.02.015.
[5] S. Amor, F. Puentes, D. Baker, P. Van Der Valk, Inflammation in neurodegenerative diseases, Immunology 129 (2) (2010) 154–169, https://doi.org/10.1111/j.1365- 2567.2009.03225.x. Pubmed:20561356.
[6] O. Takeuchi, S. Akira, Pattern recognition receptors and inflammation, Cell 140 (6) (2010) 805–820, https://doi.org/10.1016/j.cell.2010.01.022. Pubmed:20303872.
[7] G.P. Williams, D.J. Marmion, A.M. Schonhoff, A. Jurkuvenaite, W.J. Won, D. G. Standaert, J.H. Kordower, A.S. Harms, T cell infiltration in both human multiple system atrophy and a novel mouse model of the disease, Acta Neuropathol. 139 (5) (2020) 855–874, https://doi.org/10.1007/s00401-020-02126-w. Pubmed: 31993745. Y. Inoue et al.
[8] A. Nazmi, R.H. Field, E.W. Griffin, O. Haugh, E. Hennessy, D. Cox, R. Reis, L. Tortorelli, C.L. Murray, A.B. Lopez-Rodriguez, L. Jin, E.C. Lavelle, A. Dunne, C. Cunningham, Chronic neurodegeneration induces type I interferon synthesis via STING, shaping microglial phenotype and accelerating disease progression, Glia 67 (7) (2019) 1254–1276, https://doi.org/10.1002/glia.23592. Pubmed:30680794.
[9] E.R. Roy, B. Wang, Y.W. Wan, G. Chiu, A. Cole, Z. Yin, N.E. Propson, Y. Xu, J. L. Jankowsky, Z. Liu, V.M.Y. Lee, J.Q. Trojanowski, S.D. Ginsberg, O. Butovsky, H. Zheng, W. Cao, Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease, J. Clin. Invest. 130 (4) (2020) 1912–1930, https://doi.org/10.1172/JCI133737. Pubmed:31917687.
[10] D. Jakimovski, C. Kolb, M. Ramanathan, R. Zivadinov, B. Weinstock-Guttman, Interferon β for Multiple Sclerosis, Cold Spring Harb, Perspect. Med. 8 (11) (2018) a032003, https://doi.org/10.1101/cshperspect.a032003. Pubmed: 29311124.
[11] F. McNab, K. Mayer-Barber, A. Sher, A. Wack, A. O’Garra, Type I interferons in infectious disease, Nat. Rev. Immunol. 15 (2015) 87–103, https://doi.org/ 10.1038/nri3787. Pubmed: 25614319.
[12] Q. Chen, L. Sun, Z.J. Chen, Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing, Nat. Immunol. 17 (10) (2016) 1142–1149, https://doi.org/ 10.1038/ni.3558. Pubmed:27648547.
[13] Z. Zhang, B. Yuan, M. Bao, N. Lu, T. Kim, Y.J. Liu, The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells, Nat. Immunol. 12 (10) (2011) 959–965, https://doi.org/10.1038/ni.2091. Pubmed:21892174.
[14] H. Ishikawa, Z. Ma, G.N. Barber, STING regulates intracellular DNA-mediated, type 1 interferon-dependent innate immunity, Nature 461 (7265) (2009) 788–792, https://doi.org/10.1038/nature08476. Pubmed:19776740.
[15] D.A. Sliter, J. Martinez, L. Hao, X. Chen, N. Sun, T.D. Fischer, J.L. Burman, Y. Li, Z. Zhang, D.P. Narendra, H. Cai, M. Borsche, C. Klein, R.J. Youle, Parkin and PINK1 mitigate STING-induced inflammation, Nature 561 (7722) (2018) 258–262, https://doi.org/10.1038/s41586-018-0448-9. Pubmed:30135585.
[16] C.A. Thomas, L. Tejwani, C.A. Trujillo, P.D. Negraes, R.H. Herai, P. Mesci, A. Macia, Y.J. Crow, A.R. Muotri, Modeling of TREX1-dependent autoimmune disease using human stem cells highlights L1 accumulation as a source of neuroinflammation, Cell Stem Cell 21 (3) (2017) 319–331, https://doi.org/ 10.1016/j.stem.2017.07.009, e8.Pubmed:28803918.
[17] Q. Chen, A. Boire, X. Jin, M. Valiente, E.E. Er, A. Lopez-Soto, L.S. Jacob, R. Patwa, H. Shah, K. Xu, J.R. Cross, J. Massagu´e, Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer, Nature 533 (7604) (2016) 493–498, https://doi.org/10.1038/nature18268. Pubmed:27225120.
[18] T. Abe, G.N. Barber, Cytosolic-DNA-mediated, STING-dependent pro-inflammatory gene induction necessitates canonical NF− B activation through TBK1, J. Virol. 88 (10) (2014) 5328–5341, https://doi.org/10.1128/JVI.00037-14. Pubmed: 24600004.
[19] A. Abdullah, M. Zhang, T. Frugier, S. Bedoui, J.M. Taylor, P.J. Crack, STINGmediated type-I interferons contribute to the neuroinflammatory process and detrimental effects following traumatic brain injury, J. Neuroinflamm. 15 (1) (2018) 323, https://doi.org/10.1186/s12974-018-1354-7. Pubmed:30463579.
[20] A.M. Jeffries, I. Marriott, Human microglia and astrocytes express cGAS-STING viral sensing components, Neurosci. Lett. 658 (2017) 53–56, https://doi.org/ 10.1016/j.neulet.2017.08.039. Pubmed:28830822.
[21] A.U. Joshi, P.S. Minhas, S.A. Liddelow, B. Haileselassie, K.I. Andreasson, G. W. Dorn, D. Mochly-Rosen, Fragmented mitochondria released from microglia trigger A1 astrocytic response and propagate inflammatory neurodegeneration, Nat. Neurosci. 22 (10) (2019) 1635–1648, https://doi.org/10.1038/s41593-019- 0486-0. Pubmed:31551592.
[22] G. Monzio Compagnoni, G. Kleiner, M. Samarani, M. Aureli, G. Faustini, A. Bellucci, D. Ronchi, A. Bordoni, M. Garbellini, S. Salani, F. Fortunato, E. Frattini, E. Abati, C. Bergamini, R. Fato, S. Tabano, M. Miozzo, G. Serratto, M. Passafaro, M. Deleidi, R. Silipigni, M. Nizzardo, N. Bresolin, G.P. Comi, S. Corti, C.M. Quinzii, A. Di Fonzo, Mitochondrial dysregulation and impaired autophagy in iPSC-derived dopaminergic neurons of multiple system atrophy, Stem Cell Rep. 11 (5) (2018) 1185–1198, https://doi.org/10.1016/j.stemcr.2018.09.007. Pubmed:30344007.
[23] Z. Krejciova, G.A. Carlson, K. Giles, S.B. Prusiner, Replication of multiple system atrophy prions in primary astrocyte cultures from transgenic mice expressing human α-synuclein, Acta Neuropathol, Commun. 7 (2019) 1–19, https://doi.org/ 10.1186/s40478-019-0703-9. Pubmed: 31109379.
[24] F. Ma, B. Li, Y. Yu, S.S. Iyer, M. Sun, G. Cheng, Positive feedback regulation of type I interferon by the interferon-stimulated gene STING [EMBO rep.], EMBO Rep. 16 (2) (2015) 202–212, https://doi.org/10.15252/embr.201439366. Pubmed: 25572843.
[25] T. Goldmann, T. Blank, M. Prinz, Fine-tuning of type I IFN-signaling in microglia - Implications for homeostasis, CNS autoimmunity and interferonopathies, Curr. Opin. Neurobiol. 36 (2016) 38–42, https://doi.org/10.1016/j.conb.2015.09.003. Pubmed:26397019.
[26] Y. Zhang, B.A. Barres, Astrocyte heterogeneity: an underappreciated topic in neurobiology, Curr. Opin. Neurobiol. 20 (5) (2010) 588–594, https://doi.org/ 10.1016/j.conb.2010.06.005. Pubmed:20655735.
[27] B.P. Daniels, H. Jujjavarapu, D.M. Durrant, J.L. Williams, R.R. Green, J.P. White, H.M. Lazear, M. Gale, M.S. Diamond, R.S. Klein, Regional astrocyte IFN signaling restricts pathogenesis during neurotropic viral infection, J. Clin. Invest. 127 (3) (2017) 843–856, https://doi.org/10.1172/JCI88720. Pubmed:28134626.
[28] E. Matsusue, S. Fujii, Y. Kanasaki, S. Sugihara, H. Miyata, E. Ohama, T. Ogawa, Putaminal lesion in multiple system atrophy: Postmortem MR-pathological correlations, Neuroradiology 50 (7) (2008) 559–567, https://doi.org/10.1007/ s00234-008-0381-y. Pubmed:18463858.